English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    T.O. Rekun, Yu.Yu. Trofimenko, M.V. Balynska, I.V. Loboda

    PARTICIPATION OF INTESTINAL DIFFERENTIATION TRANSCRIPTION FACTOR CDX2 IN THE HISTOGENESIS OF THE GASTROINTESTINAL TRACT


    About the author: T.O. Rekun, Yu.Yu. Trofimenko, M.V. Balynska, I.V. Loboda
    Heading EXPERIMENTAL MEDICINE
    Type of article Scentific article
    Annotation The purpose of the present study was to explore expression and role of CDX2 in the differentiation of anterior and posterior parts of the gastrointestinal tract in the human embryos and fetuses in gestation age 4-38 weeks. The current study was carried out on 169 autopsied formalin-fixed human embryos and fetuses of gestational age 4–38 weeks of Caucasian ethnic origin. It was found that expression of CDX2 was negative in all cases as in esophageal so in gastric epithelium, despite its moderate expression in small and large intestine. This indicates that CDX2 is important transcription factor of development and differentiation of exactly intestinal epithelium. According to this view, immunohistochemical and functional experimental investigations point to appropriate CDX2 expression during the Barrett’s esophagus formation and on the contrary conditional removal of CDX2 in the intestine causes squamous metaplasia. Expression of intestinal differentiation transcription factor CDX2 was typical for epithelial differon of lower parts of the gastrointestinal tract and wasn’t noticed by us in the enterocytes nuclei of the esophagus and stomach.
    Tags embryogenesis, transcription factor CDX2, gastroesophageal and intestinal epithelium, gastrointestinal tract
    Bibliography
    • Antonyuk ОP. Morphogenesis of the esophageal-gastric transition in the early period of human ontogenesis. Bulletin of Biology and Medicine. 2014; 2(3): 241-246.
    • Barros R, Pereira D, Callé C, Camilo V, Cunha AI, David L. [et al.]. Dynamics of SOX2 and CDX2 Expression in Barrett's Mucosa. Dis Markers. 2016; 1532791.
    • Chen H, Hu Y, Fang Y, Djukic Z, Yamamoto M, Shaheen NJ. [et al.]. Nrf2 deficiency impairs the barrier function of mouse oesophageal epithelium. Gut. 2014; 63: 711-719.
    • Chen H, Li J, Li H, Hu Y, Tevebaugh W. Transcript Profiling Identifies Dynamic Gene Expression Patterns and an Important Role for Nrf2/Keap1 Pathway in the Developing Mouse Esophagus. PLoS One. 2012; 7: e36504.
    • de Ward AD, Cramer J, Lagasse E. Cellular heterogeneity in the mouse esophagus implicates the presence of a nonquiescent epithelial stem cell population. Cell Rep. 2014; 9: 701-711.
    • Domyan ET, Ferretti E, Throckmorton K, Mishina Y, Nicolis SK. Signaling through BMP receptors promotes respiratory identity in the foregut via repression of Sox2. Sun Development. 2011; 138: 971-981.
    • Herfs M, Hubert P, Delvenne P. Epithelial metaplasia: adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation? Trends Mol. Med. 2009; 15: 245-253.
    • Kang JM, Lee BH, Kim N. CDX1 and CDX2 Expression in Intestinal Metaplasia, Dysplasia and Gastric Cancer. J. Korean Med. Sci. 2011; 26(5): 647-653.
    • Kim TH, Shivdasani RA. Stomach development, stem cells and disease. Development. 2016; 143(4): 554-565.
    • Le Guen L, Marchal S, Faure S, de Santa Barbara P. Mesenchymal-epithelial interactions during digestive tract development and epithelial stem cell regeneration. Cell Mol. Life Sci. 2015; 72(20): 3883-3896.
    • Liu K, Jiang M, Lu Y, Chen H, Sun J. Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells. Cell Stem. Cell. 2013; 12: 304-315.
    • Mills JC, Sansom OJ. Reserve stem cells. Differentiated cells reprogram to fuel repair, metaplasia, and neoplasia in the adult gastrointestinal tract. Sci Signal. 2015; 8(385): re8.
    • Niu H, Jia Y, Li T, Su B. SOX2 Inhibition Promotes Promoter Demethylation of CDX2 to Facilitate Gastric Intestinal Metaplasia. Dig. Dis. Sci. 2017; 62(1): 124-132.
    • Wang DH. The Esophageal Squamous Epithelial Cell-Still a Reasonable Candidate for the Barrett’s Esophagus Cell of Origin? Cellular and Molecular Gastroenterology and Hepatology. 2017; 4(1): 157-160.
    • Watanabe H, Ma Q, Peng S, Adelmant G, Swain D, Song W. [et al.]. SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas. J. Clin. Invest. 2014; 124: 1636-1645.
    Publication of the article «World of Medicine and Biology» №4(66), 2018 year, 198-202 pages, index UDK 611.018:616.311:57.017.642
    DOI 10.26724/2079-8334-2018-4-66-198-202